Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation

The goal of this study was to evaluate the utility of urinary metabolomics for noninvasive diagnosis of T cell–mediated rejection (TCMR) in pediatric kidney transplant recipients. Urine samples (n = 277) from 57 patients with surveillance or indication kidney biopsies were assayed for 134 unique met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2014-10, Vol.14 (10), p.2339-2349
Hauptverfasser: Blydt‐Hansen, T. D., Sharma, A., Gibson, I. W., Mandal, R., Wishart, D. S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2349
container_issue 10
container_start_page 2339
container_title American journal of transplantation
container_volume 14
creator Blydt‐Hansen, T. D.
Sharma, A.
Gibson, I. W.
Mandal, R.
Wishart, D. S.
description The goal of this study was to evaluate the utility of urinary metabolomics for noninvasive diagnosis of T cell–mediated rejection (TCMR) in pediatric kidney transplant recipients. Urine samples (n = 277) from 57 patients with surveillance or indication kidney biopsies were assayed for 134 unique metabolites by quantitative mass spectrometry. Samples without TCMR (n = 183) were compared to borderline tubulitis (n = 54) and TCMR (n = 30). Partial least squares discriminant analysis identified distinct classifiers for TCMR (area under receiver operating characteristic curve [AUC] = 0.892; 95% confidence interval [CI] 0.827–0.957) and borderline tubulitis (AUC = 0.836; 95% CI 0.781–0.892), respectively. Application of the TCMR classifier to borderline tubulitis samples yielded a discriminant score (−0.47 ± 0.33) mid‐way between TCMR (−0.20 ± 0.34) and No TCMR (−0.80 ± 0.32) (p 
doi_str_mv 10.1111/ajt.12837
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1563982056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3434176481</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4887-3c3ea04356431759a39ad6874676c8f33f9b019602aebf3deed78690d6d22a733</originalsourceid><addsrcrecordid>eNp10c1uEzEQB3ALgWgbOPACyBJCKoe0_ti1vccQvmlBQul55dizwpFjp7a3KDfuHHlDngSnCUVCwpfx4efxaP4IPaHkjNZzrlfljDLF5T10TAUhU0Ebfv_uztsjdJLzihAqmWIP0RFrKVeENcfox1VyQactvoSil9HHtTMZDzHhTzG4cKOzuwH8CgqY4mLAccAvY7KQvAuAdbB4ZsYCeIHn4P2v7z8vwTpdwOIvsDq8cQHPvzpvEwQ8Gwok_NHZAFu8SDrkjdeh6B18hB4M2md4fKgTdPXm9WL-bnrx-e37-exiahql5JQbDpo0vBUNp7LtNO-0FUo2QgqjBs6HbkloJwjTsBy4BbBSiY5YYRnTkvMJOt333aR4PUIu_dplU8fXAeKYe9oK3ilGapmgZ__QVRxTqNPtFGsawSWp6sVemRRzTjD0m-TWdas9Jf0uob4m1N8mVO3TQ8dxuQZ7J_9EUsHzA9DZaD_UHRmX_zrVNa24He187745D9v__9jPPiz2X_8GeteoXw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1562446370</pqid></control><display><type>article</type><title>Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Blydt‐Hansen, T. D. ; Sharma, A. ; Gibson, I. W. ; Mandal, R. ; Wishart, D. S.</creator><creatorcontrib>Blydt‐Hansen, T. D. ; Sharma, A. ; Gibson, I. W. ; Mandal, R. ; Wishart, D. S.</creatorcontrib><description>The goal of this study was to evaluate the utility of urinary metabolomics for noninvasive diagnosis of T cell–mediated rejection (TCMR) in pediatric kidney transplant recipients. Urine samples (n = 277) from 57 patients with surveillance or indication kidney biopsies were assayed for 134 unique metabolites by quantitative mass spectrometry. Samples without TCMR (n = 183) were compared to borderline tubulitis (n = 54) and TCMR (n = 30). Partial least squares discriminant analysis identified distinct classifiers for TCMR (area under receiver operating characteristic curve [AUC] = 0.892; 95% confidence interval [CI] 0.827–0.957) and borderline tubulitis (AUC = 0.836; 95% CI 0.781–0.892), respectively. Application of the TCMR classifier to borderline tubulitis samples yielded a discriminant score (−0.47 ± 0.33) mid‐way between TCMR (−0.20 ± 0.34) and No TCMR (−0.80 ± 0.32) (p &lt; 0.001 for all comparisons). Discriminant scoring for combined borderline/TCMR versus No TCMR (AUC = 0.900; 95% CI 0.859–0.940) applied to a validation cohort robustly distinguished between samples with (−0.08 ± 0.52) and without (−0.65 ± 0.54, p &lt; 0.001) borderline/TCMR (p &lt; 0.001). The TCMR discriminant score was driven by histological t‐score, ct‐score, donor‐specific antibody and biopsy indication, and was unaffected by renal function, interstitial or microcirculatory inflammation, interstitial fibrosis or pyuria. These preliminary findings suggest that urinary metabolomics is a sensitive, specific and noninvasive tool for TCMR identification that is superior to serum creatinine, with minimal confounding by other allograft injury processes. This study identifies patterns of urinary metabolites associated with the presence and severity of T cell‐mediated rejection, highlighting the potential utility of urinary metabolomics for noninvasive monitoring.</description><identifier>ISSN: 1600-6135</identifier><identifier>EISSN: 1600-6143</identifier><identifier>DOI: 10.1111/ajt.12837</identifier><identifier>PMID: 25138024</identifier><language>eng</language><publisher>Hoboken, NJ: Wiley</publisher><subject>Adolescent ; Biological and medical sciences ; Biomarker ; Child ; clinical research ; Female ; General aspects ; Graft Rejection - immunology ; Humans ; Kidney Transplantation ; Male ; Mass Spectrometry ; Medical sciences ; Metabolomics ; nephrology ; pediatrics ; practice ; protocol biopsy ; rejection: acute ; rejection: T cell–mediated (TCMR) ; science ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; T-Lymphocytes - immunology ; translational research ; Urine</subject><ispartof>American journal of transplantation, 2014-10, Vol.14 (10), p.2339-2349</ispartof><rights>Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4887-3c3ea04356431759a39ad6874676c8f33f9b019602aebf3deed78690d6d22a733</citedby><cites>FETCH-LOGICAL-c4887-3c3ea04356431759a39ad6874676c8f33f9b019602aebf3deed78690d6d22a733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajt.12837$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajt.12837$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28945656$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25138024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blydt‐Hansen, T. D.</creatorcontrib><creatorcontrib>Sharma, A.</creatorcontrib><creatorcontrib>Gibson, I. W.</creatorcontrib><creatorcontrib>Mandal, R.</creatorcontrib><creatorcontrib>Wishart, D. S.</creatorcontrib><title>Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation</title><title>American journal of transplantation</title><addtitle>Am J Transplant</addtitle><description>The goal of this study was to evaluate the utility of urinary metabolomics for noninvasive diagnosis of T cell–mediated rejection (TCMR) in pediatric kidney transplant recipients. Urine samples (n = 277) from 57 patients with surveillance or indication kidney biopsies were assayed for 134 unique metabolites by quantitative mass spectrometry. Samples without TCMR (n = 183) were compared to borderline tubulitis (n = 54) and TCMR (n = 30). Partial least squares discriminant analysis identified distinct classifiers for TCMR (area under receiver operating characteristic curve [AUC] = 0.892; 95% confidence interval [CI] 0.827–0.957) and borderline tubulitis (AUC = 0.836; 95% CI 0.781–0.892), respectively. Application of the TCMR classifier to borderline tubulitis samples yielded a discriminant score (−0.47 ± 0.33) mid‐way between TCMR (−0.20 ± 0.34) and No TCMR (−0.80 ± 0.32) (p &lt; 0.001 for all comparisons). Discriminant scoring for combined borderline/TCMR versus No TCMR (AUC = 0.900; 95% CI 0.859–0.940) applied to a validation cohort robustly distinguished between samples with (−0.08 ± 0.52) and without (−0.65 ± 0.54, p &lt; 0.001) borderline/TCMR (p &lt; 0.001). The TCMR discriminant score was driven by histological t‐score, ct‐score, donor‐specific antibody and biopsy indication, and was unaffected by renal function, interstitial or microcirculatory inflammation, interstitial fibrosis or pyuria. These preliminary findings suggest that urinary metabolomics is a sensitive, specific and noninvasive tool for TCMR identification that is superior to serum creatinine, with minimal confounding by other allograft injury processes. This study identifies patterns of urinary metabolites associated with the presence and severity of T cell‐mediated rejection, highlighting the potential utility of urinary metabolomics for noninvasive monitoring.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Biomarker</subject><subject>Child</subject><subject>clinical research</subject><subject>Female</subject><subject>General aspects</subject><subject>Graft Rejection - immunology</subject><subject>Humans</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Metabolomics</subject><subject>nephrology</subject><subject>pediatrics</subject><subject>practice</subject><subject>protocol biopsy</subject><subject>rejection: acute</subject><subject>rejection: T cell–mediated (TCMR)</subject><subject>science</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>T-Lymphocytes - immunology</subject><subject>translational research</subject><subject>Urine</subject><issn>1600-6135</issn><issn>1600-6143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10c1uEzEQB3ALgWgbOPACyBJCKoe0_ti1vccQvmlBQul55dizwpFjp7a3KDfuHHlDngSnCUVCwpfx4efxaP4IPaHkjNZzrlfljDLF5T10TAUhU0Ebfv_uztsjdJLzihAqmWIP0RFrKVeENcfox1VyQactvoSil9HHtTMZDzHhTzG4cKOzuwH8CgqY4mLAccAvY7KQvAuAdbB4ZsYCeIHn4P2v7z8vwTpdwOIvsDq8cQHPvzpvEwQ8Gwok_NHZAFu8SDrkjdeh6B18hB4M2md4fKgTdPXm9WL-bnrx-e37-exiahql5JQbDpo0vBUNp7LtNO-0FUo2QgqjBs6HbkloJwjTsBy4BbBSiY5YYRnTkvMJOt333aR4PUIu_dplU8fXAeKYe9oK3ilGapmgZ__QVRxTqNPtFGsawSWp6sVemRRzTjD0m-TWdas9Jf0uob4m1N8mVO3TQ8dxuQZ7J_9EUsHzA9DZaD_UHRmX_zrVNa24He187745D9v__9jPPiz2X_8GeteoXw</recordid><startdate>201410</startdate><enddate>201410</enddate><creator>Blydt‐Hansen, T. D.</creator><creator>Sharma, A.</creator><creator>Gibson, I. W.</creator><creator>Mandal, R.</creator><creator>Wishart, D. S.</creator><general>Wiley</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201410</creationdate><title>Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation</title><author>Blydt‐Hansen, T. D. ; Sharma, A. ; Gibson, I. W. ; Mandal, R. ; Wishart, D. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4887-3c3ea04356431759a39ad6874676c8f33f9b019602aebf3deed78690d6d22a733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Biomarker</topic><topic>Child</topic><topic>clinical research</topic><topic>Female</topic><topic>General aspects</topic><topic>Graft Rejection - immunology</topic><topic>Humans</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Metabolomics</topic><topic>nephrology</topic><topic>pediatrics</topic><topic>practice</topic><topic>protocol biopsy</topic><topic>rejection: acute</topic><topic>rejection: T cell–mediated (TCMR)</topic><topic>science</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>T-Lymphocytes - immunology</topic><topic>translational research</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blydt‐Hansen, T. D.</creatorcontrib><creatorcontrib>Sharma, A.</creatorcontrib><creatorcontrib>Gibson, I. W.</creatorcontrib><creatorcontrib>Mandal, R.</creatorcontrib><creatorcontrib>Wishart, D. S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blydt‐Hansen, T. D.</au><au>Sharma, A.</au><au>Gibson, I. W.</au><au>Mandal, R.</au><au>Wishart, D. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation</atitle><jtitle>American journal of transplantation</jtitle><addtitle>Am J Transplant</addtitle><date>2014-10</date><risdate>2014</risdate><volume>14</volume><issue>10</issue><spage>2339</spage><epage>2349</epage><pages>2339-2349</pages><issn>1600-6135</issn><eissn>1600-6143</eissn><abstract>The goal of this study was to evaluate the utility of urinary metabolomics for noninvasive diagnosis of T cell–mediated rejection (TCMR) in pediatric kidney transplant recipients. Urine samples (n = 277) from 57 patients with surveillance or indication kidney biopsies were assayed for 134 unique metabolites by quantitative mass spectrometry. Samples without TCMR (n = 183) were compared to borderline tubulitis (n = 54) and TCMR (n = 30). Partial least squares discriminant analysis identified distinct classifiers for TCMR (area under receiver operating characteristic curve [AUC] = 0.892; 95% confidence interval [CI] 0.827–0.957) and borderline tubulitis (AUC = 0.836; 95% CI 0.781–0.892), respectively. Application of the TCMR classifier to borderline tubulitis samples yielded a discriminant score (−0.47 ± 0.33) mid‐way between TCMR (−0.20 ± 0.34) and No TCMR (−0.80 ± 0.32) (p &lt; 0.001 for all comparisons). Discriminant scoring for combined borderline/TCMR versus No TCMR (AUC = 0.900; 95% CI 0.859–0.940) applied to a validation cohort robustly distinguished between samples with (−0.08 ± 0.52) and without (−0.65 ± 0.54, p &lt; 0.001) borderline/TCMR (p &lt; 0.001). The TCMR discriminant score was driven by histological t‐score, ct‐score, donor‐specific antibody and biopsy indication, and was unaffected by renal function, interstitial or microcirculatory inflammation, interstitial fibrosis or pyuria. These preliminary findings suggest that urinary metabolomics is a sensitive, specific and noninvasive tool for TCMR identification that is superior to serum creatinine, with minimal confounding by other allograft injury processes. This study identifies patterns of urinary metabolites associated with the presence and severity of T cell‐mediated rejection, highlighting the potential utility of urinary metabolomics for noninvasive monitoring.</abstract><cop>Hoboken, NJ</cop><pub>Wiley</pub><pmid>25138024</pmid><doi>10.1111/ajt.12837</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1600-6135
ispartof American journal of transplantation, 2014-10, Vol.14 (10), p.2339-2349
issn 1600-6135
1600-6143
language eng
recordid cdi_proquest_miscellaneous_1563982056
source Wiley Online Library - AutoHoldings Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Biological and medical sciences
Biomarker
Child
clinical research
Female
General aspects
Graft Rejection - immunology
Humans
Kidney Transplantation
Male
Mass Spectrometry
Medical sciences
Metabolomics
nephrology
pediatrics
practice
protocol biopsy
rejection: acute
rejection: T cell–mediated (TCMR)
science
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
T-Lymphocytes - immunology
translational research
Urine
title Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A42%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urinary%20Metabolomics%20for%20Noninvasive%20Detection%20of%20Borderline%20and%20Acute%20T%20Cell%E2%80%93Mediated%20Rejection%20in%20Children%20After%20Kidney%20Transplantation&rft.jtitle=American%20journal%20of%20transplantation&rft.au=Blydt%E2%80%90Hansen,%20T.%20D.&rft.date=2014-10&rft.volume=14&rft.issue=10&rft.spage=2339&rft.epage=2349&rft.pages=2339-2349&rft.issn=1600-6135&rft.eissn=1600-6143&rft_id=info:doi/10.1111/ajt.12837&rft_dat=%3Cproquest_cross%3E3434176481%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1562446370&rft_id=info:pmid/25138024&rfr_iscdi=true